D-dimer Testing Market to Reach US$ 2,269.31 Million by 2032 Supported by Growing Thromboembolic Disease Burden and Expansion of Point-of-Care Diagnostics Says Astute Analytica

The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.
The BMJ

Anticoagulation to prevent dementia . . . and other research

Tom Nolan reviews this week’s research An editorial about D-dimers likens the endlessly talked about blood test to a fine wine. It’s nothing to do with its taste (I find it a bit claggy) or cost, but ...
TCTMD

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ADJUST-DVT trial. For patients ages 50 and older with a nonhigh or unlikely ...